BAKER BROS. ADVISORS LP 13D and 13G filings for IGM Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-28 7:13 pm Purchase |
2024-03-28 | 13D | IGM Biosciences, Inc. IGMS |
BAKER BROS. ADVISORS LP | 4,145,706 12.400% |
401,037 (+10.71%) |
Filing |
| 2023-12-15 5:20 pm Purchase |
2023-12-15 | 13D | IGM Biosciences, Inc. IGMS |
BAKER BROS. ADVISORS LP | 3,744,669 11.400% |
467,102 (+14.25%) |
Filing |
| 2023-06-28 5:01 pm Purchase |
2023-06-22 | 13D | IGM Biosciences, Inc. IGMS |
BAKER BROS. ADVISORS LP | 3,277,567 9.990% |
107,673 (+3.40%) |
Filing |
| 2022-04-05 5:15 pm Purchase |
2022-03-29 | 13D | IGM Biosciences, Inc. IGMS |
BAKER BROS. ADVISORS LP | 3,169,894 11.600% |
12,110 (+0.38%) |
Filing |
| 2021-01-29 5:03 pm Purchase |
2021-01-23 | 13D | IGM Biosciences, Inc. IGMS |
BAKER BROS. ADVISORS LP | 3,157,784 12.400% |
513 (+0.02%) |
Filing |
| 2021-01-05 5:14 pm Sale |
2021-01-05 | 13D | IGM Biosciences, Inc. IGMS |
BAKER BROS. ADVISORS LP | 3,157,271 12.400% |
-35,751 (-1.12%) |
Filing |
| 2020-12-11 5:28 pm Purchase |
2020-12-07 | 13D | IGM Biosciences, Inc. IGMS |
BAKER BROS. ADVISORS LP | 3,193,022 9.990% |
49,022 (+1.56%) |
Filing |